CD37 binding to radioimmunoconjugate human pharmaceutical composition use of radioimmunoconjugate method for treating a B-cell malignancy and kit for production of radioimmunoconjugate
The present invention relates to a radioimmunoconjugate that binds human CD37. Pharmaceutical compositions and uses thereof for the treatment of cancer - and in particular B-cell malignancies - are aspects of the present invention.